Author details

Full Name

Jami McLaughlin

Affiliation

University of California los angeles

ORCID

Career Start Year

1983

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37192158	IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing.	Proc Natl Acad Sci U S A	2023
35878026	Physical and in silico immunopeptidomic profiling of a cancer antigen prostatic acid phosphatase reveals targets enabling TCR isolation.	Proc Natl Acad Sci U S A	2022
33431692	Droplet-based mRNA sequencing of fixed and permeabilized cells by CLInt-seq allows for antigen-specific TCR cloning.	Proc Natl Acad Sci U S A	2021
34919800	HLA-A<sup>â¿¿</sup>02:01 restricted TÂ cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses.	Cell Rep	2021
31484081	Sensitive Detection and Analysis of Neoantigen-Specific T Cell Populations from Tumors and Blood.	Cell Rep	2019
31495780	Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer.	Cell Stem Cell	2019
30348802	Isolation and characterization of NY-ESO-1-specific T cell receptors restricted on various MHC molecules.	Proc Natl Acad Sci U S A	2018
28190001	Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1<sup>+</sup> pre-B ALL.	J Exp Med	2017
25605948	Genetic engineering of hematopoietic stem cells to generate invariant natural killer T cells.	Proc Natl Acad Sci U S A	2015
25822024	Noninvasive detection of tumor-infiltrating T cells by PET reporter imaging.	J Clin Invest	2015
25101980	Deoxycytidine kinase augments ATM-Mediated DNA repair and contributes to radiation resistance.	PLoS One	2014
23319634	Long-term in vivo monitoring of mouse and human hematopoietic stem cell engraftment with a human positron emission tomography reporter gene.	Proc Natl Acad Sci U S A	2013
24013668	Selective regulation of lymphopoiesis and leukemogenesis by individual zinc fingers of Ikaros.	Nat Immunol	2013
21102429	ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1.	Leukemia	2011
19190791	An integrated microfluidic culture device for quantitative analysis of human embryonic stem cells.	Lab Chip	2009
17145776	Vascular abnormalities in mice deficient for the G protein-coupled receptor GPR4 that functions as a pH sensor.	Mol Cell Biol	2007
18079287	Sustained suppression of Bcr-Abl-driven lymphoid leukemia by microRNA mimics.	Proc Natl Acad Sci U S A	2007
17554060	Age-related defects in B lymphopoiesis underlie the myeloid dominance of adult leukemia.	Blood	2007
16382156	Normal immune development and glucocorticoid-induced thymocyte apoptosis in mice deficient for the T-cell death-associated gene 8 receptor.	Mol Cell Biol	2006
15665078	Differential proton sensitivity of related G protein-coupled receptors T cell death-associated gene 8 and G2A expressed in immune cells.	Proc Natl Acad Sci U S A	2005
15505216	Sole BCR-ABL inhibition is insufficient to eliminate all myeloproliferative disorder cell populations.	Proc Natl Acad Sci U S A	2004
12521991	Cell context-specific effects of the BCR-ABL oncogene monitored in hematopoietic progenitors.	Blood	2003
14500898	IL-3 receptor signaling is dispensable for BCR-ABL-induced myeloproliferative disease.	Proc Natl Acad Sci U S A	2003
9844916	Dissection of signaling pathways and cloning of new signal transducers in tyrosine kinase-induced pathways by genetic selection.	Leukemia	1998
9208849	Regulation of the oncogenic activity of BCR-ABL by a tightly bound substrate protein RIN1.	Immunity	1997
8754809	Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia.	Mol Cell Biol	1996
7553858	Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene.	Cell	1995
7807010	Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr-Abl oncogene.	J Exp Med	1995
7568169	Signaling by ABL oncogenes through cyclin D1.	Proc Natl Acad Sci U S A	1995
7512450	The nuclear tyrosine kinase c-Abl negatively regulates cell growth.	Cell	1994
8153630	Differential complementation of Bcr-Abl point mutants with c-Myc.	Science	1994
7587117	Genetic approaches to defining signaling by the CML-associated tyrosine kinase BCR-ABL.	Cold Spring Harb Symp Quant Biol	1994
8336729	Oncogenic activation of c-ABL by mutation within its last exon.	Mol Cell Biol	1993
1875948	Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene.	Mol Cell Biol	1991
1886706	The 5' non-coding region of the BCR/ABL oncogene augments its ability to stimulate the growth of immature lymphoid cells.	Oncogene	1991
2204061	Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.	Proc Natl Acad Sci U S A	1990
2140191	Base changes at position 792 of Escherichia coli 16S rRNA affect assembly of 70S ribosomes.	Proc Natl Acad Sci U S A	1990
2747638	Alternative forms of the BCR-ABL oncogene have quantitatively different potencies for stimulation of immature lymphoid cells.	Mol Cell Biol	1989
3422516	Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL).	Science	1988
2440107	The CML-specific P210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts.	Science	1987
3541203	Unique forms of the abl tyrosine kinase distinguish Ph1-positive CML from Ph1-positive ALL.	Science	1987
3498165	In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome.	Proc Natl Acad Sci U S A	1987
3127280	Molecular cloning and serological characterization of an altered c-abl gene product produced in Ph1 CML patients.	Haematol Blood Transfus	1987
3012546	Variable expression of the translocated c-abl oncogene in Philadelphia-chromosome-positive B-lymphoid cell lines from chronic myelogenous leukemia patients.	Proc Natl Acad Sci U S A	1986
3540951	Overlapping cDNA clones define the complete coding region for the P210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome.	Proc Natl Acad Sci U S A	1986
6325950	Long terminal repeats of human T-cell leukaemia virus II genome determine target cell specificity.	Nature	1984
6312323	Molecular characterization of genome of a novel human T-cell leukaemia virus.	Nature	1983

1 - 47 of 47

Anupriya Agarwal

Knight Cancer Institute, Oregon Health & Science University

Career Start Year 2006

Number of shared co-authors 0

Mateusz Koptyra

Children's Hospital of Philadelphia

Career Start Year 2004

Number of shared co-authors 0

Anna M Eiring

Texas Tech University Health Sciences Center at El Paso

Career Start Year 2004

Number of shared co-authors 0

Jeffrey W Tyner

Oregon Health & Science University School of Medicine

Career Start Year 2002

Number of shared co-authors 1

Eric P Stoffregen

Lewis-Clark State College

Career Start Year 2002

Number of shared co-authors 0

Dorian LaTocha

Knight Cancer Institute, Oregon Health & Science University

Career Start Year 2000

Number of shared co-authors 0

Michael W Deininger

University of Utah Huntsman Cancer Institute

Career Start Year 1997

Number of shared co-authors 3

Brian J P Huntly

University of Cambridge

Career Start Year 1996

Number of shared co-authors 2

Jean Soulier

University of Paris

Career Start Year 1993

Number of shared co-authors 0

Timothy A Graubert

Massachusetts General Hospital

Career Start Year 1993

Number of shared co-authors 0

Benjamin S Braun

Benioff Children's Hospitals, University of California san francisco

Career Start Year 1992

Number of shared co-authors 2

Ravi Bhatia

University of Alabama at Birmingham

Career Start Year 1992

Number of shared co-authors 2

Kara Johnson

Knight Cancer Institute, Oregon Health & Science University

Career Start Year 1991

Number of shared co-authors 0

Marc M Loriaux

Knight Cancer Institute, Oregon Health & Science University

Career Start Year 1991

Number of shared co-authors 1

Johanna Ten Hoeve

California Nanosystems Institute, University of California los angeles

Career Start Year 1990

Number of shared co-authors 2

Jana Krosl

The Leucegene Project at Institute for Research in Immunology and Cancer.

Career Start Year 1989

Number of shared co-authors 0

Geoffrey Neale

St. Jude Children's Research Hospital

Career Start Year 1989

Number of shared co-authors 1

Junia V Melo

University of Adelaide

Career Start Year 1984

Number of shared co-authors 2

Toshio Kitamura

The University of Tokyo.

Career Start Year 1984

Number of shared co-authors 1

Giorgio Inghirami

Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital

Career Start Year 1984

Number of shared co-authors 1

Louis M Staudt

National Cancer Institute, National Institutes of Health

Career Start Year 1983

Number of shared co-authors 1

Bertram Opalka

University Hospital Essen.

Career Start Year 1982

Number of shared co-authors 0

Timothy J Ley

Washington University School of Medicine

Career Start Year 1982

Number of shared co-authors 0

Trang Hoang

Department of Biomedical Science and Center for Bio-Nanomaterials, Daegu University

Career Start Year 1981

Number of shared co-authors 0

Brian Van Ness

University of Minnesota

Career Start Year 1978

Number of shared co-authors 1

Riccardo Dalla-Favera

Institute for Cancer Genetics, Columbia University

Career Start Year 1978

Number of shared co-authors 1

Brian J Druker

Oregon Health & Science University

Career Start Year 1978

Number of shared co-authors 3

Curt I Civin

Center for Stem Cell Biology & Regenerative Medicine and.

Career Start Year 1976

Number of shared co-authors 0

Daniel G Tenen

Harvard Stem Cell Institute, Harvard Medical School

Career Start Year 1975

Number of shared co-authors 1

Alex Look

Dana-Farber Cancer Institute

Career Start Year 1975

Number of shared co-authors 3

row(s) 1 - 30 of 30

Owen N Witte

University of California los angeles

Co-authored papers 44

Donghui Cheng

University of California los angeles

Co-authored papers 18

Andrei Goga

University of California San Francisco

Co-authored papers 6

Charles L Sawyers

Memorial Sloan Kettering Cancer Center

Co-authored papers 4

Pavlo A Nesterenko

Oregon Health and Science University

Co-authored papers 4

Antoni Ribas

University of California Los Angeles (university of california los angeles)

Co-authored papers 4

Nathanael J Bangayan

University of California los angeles

Co-authored papers 4

James R Heath

Institute of Systems Biology, University of Washington

Co-authored papers 4

Zhiyuan Mao

College of Life Science and Engineering, Southwest Jiaotong University

Co-authored papers 4

John W Phillips

University of California los angeles

Co-authored papers 4

Yapeng Su

Fred Hutchinson Cancer Research Center, USA Clinical Research Division

Co-authored papers 2

George Q Daley

Boston Children's Hospital, Harvard Medical School

Co-authored papers 2

Camille Carmona

University of California los angeles

Co-authored papers 1

Kevan M Shokat

University of California San Francisco

Co-authored papers 1

Inder M Verma

Co-authored papers 1

Lili Yang

University of California Los Angeles

Co-authored papers 1

Giselle Burton Sojo

University of California los angeles

Co-authored papers 1

Rachel H Ng

Institute for Systems Biology, University of Washington

Co-authored papers 1

Todd R Golub

Broad Institute of MIT and Harvard

Co-authored papers 1

Jesse M Zaretsky

University of California los angeles

Co-authored papers 1

Robert J Kay

University of Toronto

Co-authored papers 1

Hsian-Rong Tseng

Jonsson Comprehensive Cancer Center, University of California los angeles

Co-authored papers 1

Paul C Boutros

University of California los angeles

Co-authored papers 1

William Chour

Co-authored papers 1

Derek Lee

University of California los angeles

Co-authored papers 1

Miyako Noguchi

University of California los angeles

Co-authored papers 1

Charles J Sherr

St. Jude Children's Research Hospital

Co-authored papers 1

Jonathan Cebon

Australia Olivia Newton-John Cancer Research Institute, La Trobe University

Co-authored papers 1

Daniel Zhao

New York Medical College

Co-authored papers 1

Jingyi Xie

Institute for Systems Biology, University of Washington

Co-authored papers 1

1 - 30

Author Details

Column Actions

Recommended Authors

Collaborators